Nucala 100MG/ML 1ML 1S
Ended Awarded Last action
- Contract number
- SPE2DR26FBTHV
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,591
Award facts
- Contract value 100% obligated
- $11,590.98 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a firm fixed-price delivery order valued at $11,590.98 to DMS Pharmaceutical Group Inc. for NUCALA (mepolizumab) 100mg/mL injection, 1mL single-use vials. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation, demonstrating the company's competitive capability in unrestricted federal procurement. The delivery order is effective through December 19, 2025, and represents one of numerous orders issued to the vendor under its broader pharmaceutical supply contract.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, designated as contract SPE2DR. The parent contract, valued at $499.999 billion with a completion date of December 31, 2036, positions DMS Pharmaceutical Group as a regional prime vendor contractor within the broader $30.3 billion PPV-G GEN V acquisition strategy. The IDC authorizes the Defense Logistics Agency to issue delivery orders for a comprehensive range of pharmaceutical products, including branded and generic medications, biologics, and medical consumables to support Department of Defense military healthcare facilities worldwide.
Quick answers
Who was awarded contract SPE2DR26FBTHV?
SPE2DR26FBTHV was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 18, 2025.
How much is contract SPE2DR26FBTHV worth?
The government has obligated $11,591 on SPE2DR26FBTHV.
Is contract SPE2DR26FBTHV an order under another contract?
Yes. SPE2DR26FBTHV is a delivery order under SPE2DR25D9628, an indefinite delivery contract.
Was contract SPE2DR26FBTHV competed?
The extent of competition for SPE2DR26FBTHV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award